Da Hee Han, PharmD

Most Recent Articles by Da Hee Han, PharmD

Oral Therapy for Suicidal Bipolar Depression Gets Breakthrough Designation

By Nov 13, 2018

NRX-101 combines D-cycloserine (DCS), an N-methyl-D-aspartate (NMDA) receptor antagonist, and lurasidone, a D2/5-HT2a receptor antagonist.

HHS: Updated Physical Activity Guidelines for Americans Released

By Nov 12, 2018

This guidance, updated for the first time since 2008, provides evidence-based recommendations for children (ages 3-17) and adults.

Several Asthma, Allergy Groups Express "Deep Concern" Over Primatene MIST Approval

By Nov 12, 2018

Primatene MIST was approved earlier this month for over-the-counter (OTC) use for the temporary relief of mild symptoms of intermittent asthma (eg, wheezing, tightness of chest, shortness of breath) in patients aged ≥12 years.

Once-Daily, Nebulized Bronchodilator Approved for COPD Treatment

By Nov 09, 2018

The most common adverse events reported with therapy were cough, nasopharyngitis, upper respiratory tract infection, headache, and back pain.

Nocdurna Now Available for Nocturia Due to Nocturnal Polyuria

By Nov 09, 2018

The antidiuretic effects of desmopressin are mediated by stimulation of vasopressin 2 (V2) receptors, thereby increasing water reabsorption in the kidneys, and reducing urine production.

More Articles by Da Hee Han, PharmD